Cover Image

Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials

ABSTRACTBackground This review aimed to systematically evaluate the immunogenicity and safety of the candidate Ebola virus vaccine (EVV).Methods We searched five databases for randomized controlled trials (RCTs) evaluating the effects of EVV on healthy adults. The primary outcomes were relative risk...

Full description

Saved in:

Bibliographic Details
Main Authors:	Juntao Yin (Author), Liang Zhang (Author), Chaoyang Wang (Author), Changjiang Qin (Author), Mingsan Miao (Author)
Format:	Book
Published:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis
by: Yu Liang, et al.
Published: (2021)

Immunogenicity and safety of Ebola virus vaccines in healthy adults: a systematic review and network meta-analysis
by: Alhassane Diallo, et al.
Published: (2021)

Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus
by: Daniel N. Wolfe, et al.
Published: (2020)

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial
by: Mark Turner, et al.
Published: (2020)

Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination：a meta-analysis
by: Mingjuan Yin, et al.
Published: (2018)

Randomized clinical trial of the safety and immunogenicity of the Tdap vaccine in pregnant Mexican women
by: Jesús Zacarías Villarreal Pérez, et al.
Published: (2017)

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults
by: Goran Stevanovic, et al.
Published: (2018)

A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines
by: Rasha Ashmawy, et al.
Published: (2022)

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a double blind, phase III randomized clinical trial in healthy Serbian adults
by: Goran Stevanovic, et al.
Published: (2020)

Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial
by: Michael W. Simon, et al.
Published: (2023)

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial
by: Ahmet Omma, et al.
Published: (2022)

A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly
by: Lili Huang, et al.
Published: (2019)

Ebolaviruses: New roles for old proteins.
by: Diego Cantoni, et al.
Published: (2018)

A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States
by: David Fitz-Patrick, et al.
Published: (2021)

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
by: Ngoc Huu Tran, et al.
Published: (2019)

Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial
by: Dandan Zhu, et al.
Published: (2022)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
by: Lorenz von Seidlein, et al.
Published: (2020)

Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial
by: Yan-Fei Wu, et al.
Published: (2023)

Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
by: Chad E Mire, et al.
Published: (2013)

A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine
by: Rong Tang, et al.
Published: (2020)

Safety of Staphylococcus aureus four-antigen and three-antigen vaccines in healthy adults: A meta-analysis of randomized controlled trials
by: Xiaoqun Xu, et al.
Published: (2018)

Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis
by: Jianming Guo, et al.
Published: (2023)

Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock.
by: M Kariuki Njenga, et al.
Published: (2015)

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial
by: Timo Vesikari, et al.
Published: (2020)

Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
by: Juntao Yin, et al.
Published: (2022)

One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study
by: Jialei Hu, et al.
Published: (2018)

Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial
by: Tao Huang, et al.
Published: (2024)

Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study
by: Indraneel Basu, et al.
Published: (2022)

Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial
by: Leilani Sanchez, et al.
Published: (2020)

A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants
by: Vibhu Kanchan, et al.
Published: (2020)

Safety and immunogenicity of heterologous Ad26.ZEBOV and MVA-BN®-Filo prime-boost Ebola vaccines: 6-month follow-up of a Phase I randomized trial in healthy adults
by: Macaya Douoguih, et al.
Published: (2016)

Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial
by: Shrikant Sharma, et al.
Published: (2018)

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults
by: Osamu Matsuoka, et al.
Published: (2018)

Immunogenicity and safety of high-dose hepatitis B vaccine among drug users: A randomized, open-labeled, blank-controlled trial
by: Yongliang Feng, et al.
Published: (2017)

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)
by: Randall Severance, et al.
Published: (2022)

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
by: Chukiat Sirivichayakul, et al.
Published: (2017)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults
by: Helen L. Stacey, et al.
Published: (2019)

A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age
by: Brandon Essink, et al.
Published: (2021)

Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population
by: Rebecca K. Hollenberg, et al.
Published: (2020)

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults
by: Susan B. Manoff, et al.
Published: (2019)